Dergiler / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 2

Current Trends in the Incidence of Non-small Cell Lung Cancer in Turkey: Lung Cancer Aging

Sayfa
169–172
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Primary and secondary prevention strategies should be considered in this respect and their impact on theelderly should be carefully evaluated.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Human life span has been increasing for the last centuries.
📊
Temel Bulgular & Veri:The aim of this study was to demonstrate age-specific incidencerates in patients with lung cancer.Methods: Data was obtained from hospital-based records of patients admitted to our institute between 2011 and 2019with the diagnosis of lung cancer.
💡
Sonuç & Katkı:Primary and secondary prevention strategies should be considered in this respect and their impact on theelderly should be carefully evaluated.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Human life span has been increasing for the last centuries. By virtue of advances in cancer managements,cancer in elderly population has become more common. The aim of this study was to demonstrate age-specific incidencerates in patients with lung cancer.Methods: Data was obtained from hospital-based records of patients admitted to our institute between 2011 and 2019with the diagnosis of lung cancer. After determining the age of each cancer patient, the cancer cases were divided intoeight age groups.Results: A total of 4,424 patients during the 8-year periods between were evaluated. The median age was 61 years.Compared to the SEER data from 2011 to 2015, these values were found to be 9 years younger than American patients.Lung cancer was most commonly diagnosed in people aged 55-64 years (36.3%; the second most common 65-74 years28.7%; Fig. 2). The frequency of cancer incidence, which is the median age of the patients, has increased over the years.Conclusion: The incidence of lung cancer increases with age, and elderly lung cancer patients cause serious healthproblems. Primary and secondary prevention strategies should be considered in this respect and their impact on theelderly should be carefully evaluated.

🔖

Bu Makaleye Atıf Yap

SARI, M., VATANSEVER, S. (2022). Current Trends in the Incidence of Non-small Cell Lung Cancer in Turkey: Lung Cancer Aging. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 2, 169–172. https://ajindex.com/articles/508641

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Organization WH. World Health Organization. Global Health Observatory. Geneva2018 [updated 2018. Available from: who.int/gho/database/en/
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. [CrossRef ] 3. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005;83:731– 57. [CrossRef ] 4. Country and Lending Groups, The World Bank 2019 [Available from: https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519
  3. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105:175–201. [CrossRef ] 6. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001;31:123–37. [CrossRef ] 7. Gaspar LE, Gay EG, Crawford J, Putnam JB, Herbst RS, Bonner JA. Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base. Clin Lung Cancer 2005;6:355–60. [CrossRef ] 8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49. [CrossRef ] 9. Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975-2015 2019 [Available from: http://seer. cancer.gov/archive/csr/1975_2015/ 10. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061–7. [CrossRef] 11. Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, et al. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012. J Clin Oncol 2016;34:3992–9. [CrossRef ] 12. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850–7. [CrossRef ]